Pancreatic Cancer Research

ResearcherUniversity of LouisvilleActive in the last 2 years

Young Ki Hong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6634-1367; OpenAlex author ID A5005657851. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 2 papers

Papers 5

  1. Disparities in Pancreatic Cancer Outcomes in the Disaggregated Asian American Population. Last author DOI 10.1245/s10434-023-14454-8↗
  2. ASO Author Reflections: Utilization of Disaggregated Data Unmasks Differences in Pancreatic Cancer Outcomes in the Asian American Population. Last author DOI 10.1245/s10434-023-14509-w↗
  3. Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma. First author DOI 10.1002/cti2.1430↗
  4. Evaluating the Regulatory Immunomodulation Effect of Irreversible Electroporation (IRE) in Pancreatic Adenocarcinoma. First author DOI 10.1245/s10434-018-07144-3↗
  5. The use of IRE in multi-modality treatment for oligometastatic pancreatic cancer. Co-author DOI 10.1016/j.amjsurg.2018.01.037↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Keshav Kooragayala · 2 shared papers, 2024 · strength 0.67
  2. Robert C.G. Martin · 3 shared papers, 2018–2022 · strength 0.35
  3. Harshul Pandit · 2 shared papers, 2019–2022 · strength 0.24
  4. Neal Bhutiani · 1 shared paper, 2022 · strength 0.13
  5. Yan Li · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.